Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Patrick Hurban, Ph.D. | January 13, 2016

Precision Medicine – Leveraging Genomics in Clinical Research

Part one

In part one of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the significance of genomic technologies in clinical trials. Dr. Hurban shares his perspective on genomic technologies and the future of precision medicine as well as how both will impact healthcare globally.

Watch Part two: Precision Medicine: Applying Genomics Outside of Oncology
Watch Part three: Genomics throughout the Drug Development Process

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More